Mirna Therapeutics announced their intentions to appoint Clay Siegall to their Board of Directors. Mirna Therapeutics was founded in 2007 and is based in Austin, Texas. The company’s focus is on microRNA in therapeutics. Dr. Siegall has previous experience in cancer research, and that is what the company is currently dealing with. The company’s CEO expects guidance from Dr. Siegall in the development of microRNA therapeutics.
Seattle Genetics as a biotechnological company develops clinical and preclinical products. Its foundation is on extensive research, scientific modification, and drug enhancement. Since its establishment in 1998, the company has developed and availed antibody-drug conjugate (ADC) which is used in cancer treatment. The drug is available in the market and is approved in over 60 countries. The ADC technology reduces the negative effects of chemotherapy while improving antitumor activity in the body. There are various types of ADCs and they are used for different purposes. Siegall Genetics Company is headquartered in Bothell Washington. It partners with many companies and has licenses with many others.
Clay Siegall studied Zoology at the University of Maryland. Later, he received his Ph.D. in Genetics from George Washington University. He then worked in different places such as the National Cancer Institute, the National Institute of Health and the Bristol-Myers Squibb-A pharmaceutical research institute before he co-founded Seattle Genetics. Clay Siegall is the Chairman of the Board of Directors, Chief Executive Officer of Seattle Genetics Company. He is also a board member of Alder Pharmaceuticals Inc., the Washington Biotech, Ultragenyx Pharmaceuticals, and Biomedical Association and Fred Hutchinson Cancer Research Centre.
Clay strives to take care of the unsolved medical needs in oncology. He may be the one to come up with the drug to cure cancer. Siegall has written more than 70 publications and had 15 patents. He also has various awards including the Alumnus of the Year for Computer, Math and Natural Sciences from the University of Maryland in 2013 and the Entrepreneur of the Year from Pacific Northwest from Earnest and Young in 2012. Dr. Siegall has also led in fundraising for Seattle Genetics through both public and private financing.